Cabaletta Bio(CABA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CABA Cabaletta Bio

未开盘 11-15 16:00:00 EST

3.03

-0.75

-19.84%

盘后3.12

+0.09+2.97%

19:59 EST

最高3.84	最低2.96	成交量385.29万
今开3.84	昨收3.78	日振幅23.28%
总市值1.48亿	流通市值1.25亿	总股本4,885万
成交额1,198万	换手率9.33%	流通股本4,131万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"CABA","market":"US","secType":"STK","nameCN":"Cabaletta Bio","latestPrice":3.03,"timestamp":1731704400000,"preClose":3.78,"halted":0,"volume":3852873,"hourTrading":{"tag":"盘后","latestPrice":3.12,"preClose":3.03,"latestTime":"19:59 EST","volume":6244,"amount":19632.5731,"timestamp":1731718792880},"delay":0,"floatShares":41307512,"shares":48848673,"eps":-1.921876,"marketStatus":"未开盘","marketStatusCode":0,"change":-0.75,"latestTime":"11-15 16:00:00 EST","open":3.84,"high":3.84,"low":2.96,"amount":11977728.7456305,"amplitude":0.232804,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-1.921876,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1731920400000},"adr":0,"listingDate":1571976000000,"adjPreClose":3.78,"preHourTrading":{"tag":"盘前","latestPrice":3.83,"preClose":3.78,"latestTime":"09:29 EST","volume":138,"amount":532.5399851999999,"timestamp":1731680953706},"postHourTrading":{"tag":"盘后","latestPrice":3.12,"preClose":3.03,"latestTime":"19:59 EST","volume":6244,"amount":19632.5731,"timestamp":1731718792880},"volumeRatio":4.736471849573988,"impliedVol":2.2209,"impliedVolPercentile":0.8849},"requestUrl":"/m/hq/s/CABA","defaultTab":"news","newsList":[{"id":"2483630089","title":"美国研究综述-应用材料公司、迪士尼、沃尔玛","url":"https://stock-news.laohu8.com/highlight/detail?id=2483630089","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483630089?lang=zh_cn&edition=full","pubTime":"2024-11-16 01:28","pubTimestamp":1731691712,"startTime":"0","endTime":"0","summary":"美国研究综述-应用材料公司、迪士尼、沃尔玛路透11月15日 - 华尔街证券分析师周五调整了对几家美国上市公司的评级和目标价，其中包括应用材料公司、迪士尼和沃尔玛。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241115:nL4T3MM1DA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CHX","LU1032466523.USD","LU1267930227.SGD","AMAT","AESI","AROC","BKR","AGYS","APH","AHR","BLUE","BAC","BJ","AAL","ASTS","LNG","LU0354030511.USD","ADSK","CAVA","LU0868494708.USD","AHCO","SCHW","BRX","BTM","BRZE","AMH","IE00BKVL7J92.USD","BIIB","BMY","LU1074936037.SGD","BK4588","AGCO","AFG","IE00BBT3K403.USD","LU1861217088.USD","AAP","AIN","BK4534","ASB","ARE","ARI","BV","AKYA","BL","ALGT","BE","ALK","CABA","ASND","CELC"],"gpt_icon":1},{"id":"2483372214","title":"Cabaletta Bio, Inc.盘中异动 早盘股价大跌5.16%报3.59美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483372214","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483372214?lang=zh_cn&edition=full","pubTime":"2024-11-15 22:33","pubTimestamp":1731681236,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日22时33分，Cabaletta Bio, Inc.股票出现异动，股价大幅下挫5.16%。Cabaletta Bio, Inc.股票所在的生物技术行业中，整体跌幅为1.31%。Cabaletta Bio, Inc.公司简介：Cabaletta Bio Inc 是一家临床阶段的生物技术公司，专注于发现和开发工程化 T 细胞疗法，并探索它们为 B 细胞介导的自身免疫性疾病患者提供深度和持久的、可能是治愈性治疗的潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111522335798e42ed3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111522335798e42ed3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CABA","BK4139"],"gpt_icon":0},{"id":"2483806264","title":"卡巴莱塔生物公司公布本季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2483806264","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483806264?lang=zh_cn&edition=full","pubTime":"2024-11-14 22:16","pubTimestamp":1731593773,"startTime":"0","endTime":"0","summary":"   * Cabaletta Bio Inc   报告本季度调整后每股亏损62美分，低于去年同期的每股收益-37美分。11位分析师对该季度的平均预期是每股亏损60美分。华尔街预期为每股-64美分至-54美分。* Cabaletta Bio Inc 公布的本季度每股收益为亏损 62 美分。* 公司报告的季度亏损额为 3,063 万美元。* Cabaletta Bio Inc 本季度股价下跌了 15.0%，今年迄今为止亏损了 82.3%。华尔街对卡巴莱塔生物公司 12 个月目标价的中位数为 24.00  本摘要由 LSEG 11 月 14 日 02:15 p.m. UTC 数据机器生成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"卡巴莱塔生物公司公布本季度业绩 - 收益摘要","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CABA","BK4139"],"gpt_icon":0},{"id":"2483385504","title":"Cabaletta Bio, Inc.盘中异动 股价大跌5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483385504","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483385504?lang=zh_cn&edition=full","pubTime":"2024-11-14 02:51","pubTimestamp":1731523891,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日02时51分，Cabaletta Bio, Inc.股票出现波动，股价快速跳水5.08%。Cabaletta Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.37%。Cabaletta Bio, Inc.公司简介：Cabaletta Bio Inc 是一家临床阶段的生物技术公司，专注于发现和开发工程化 T 细胞疗法，并探索它们为 B 细胞介导的自身免疫性疾病患者提供深度和持久的、可能是治愈性治疗的潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114025131971a65b6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114025131971a65b6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CABA","BK4139"],"gpt_icon":0},{"id":"2482438519","title":"Cabaletta Bio, Inc.盘中异动 大幅下跌5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482438519","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482438519?lang=zh_cn&edition=full","pubTime":"2024-11-09 01:25","pubTimestamp":1731086755,"startTime":"0","endTime":"0","summary":"北京时间2024年11月09日01时25分，Cabaletta Bio, Inc.股票出现异动，股价快速下挫5.02%。Cabaletta Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.97%。Cabaletta Bio, Inc.公司简介：Cabaletta Bio Inc 是一家临床阶段的生物技术公司，专注于发现和开发工程化 T 细胞疗法，并探索它们为 B 细胞介导的自身免疫性疾病患者提供深度和持久的、可能是治愈性治疗的潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241109012555abaea0d1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241109012555abaea0d1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CABA"],"gpt_icon":0},{"id":"2481600806","title":"Cabaletta Bio Inc   预计每股亏损60美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2481600806","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481600806?lang=zh_cn&edition=full","pubTime":"2024-11-06 22:18","pubTimestamp":1730902722,"startTime":"0","endTime":"0","summary":"   * Cabaletta Bio Inc    预计在11月7日公布截至2024年9月30日的业绩时，季度营收将不会有任何变化(预计)。*    * LSEG分析师对卡巴莱塔生物公司的平均预期是每股亏损60美分。* 华尔街对卡巴莱塔生物公司 12 个月目标价的中位数为 24.00 美元，高于其上次收盘价 4.20 美元。11月6日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Cabaletta Bio Inc   预计每股亏损60美分 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CABA"],"gpt_icon":0},{"id":"2481806655","title":"Cabaletta Bio, Inc.盘中异动 股价大涨5.00%报4.20美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481806655","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481806655?lang=zh_cn&edition=full","pubTime":"2024-11-06 04:36","pubTimestamp":1730838973,"startTime":"0","endTime":"0","summary":"北京时间2024年11月06日04时36分，Cabaletta Bio, Inc.股票出现异动，股价快速拉升5.00%。Cabaletta Bio, Inc.股票所在的生物技术行业中，整体涨幅为1.76%。Cabaletta Bio, Inc.公司简介：Cabaletta Bio Inc 是一家临床阶段的生物技术公司，专注于发现和开发工程化 T 细胞疗法，并探索它们为 B 细胞介导的自身免疫性疾病患者提供深度和持久的、可能是治愈性治疗的潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106043613aba2d784&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106043613aba2d784&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CABA"],"gpt_icon":0},{"id":"2480358061","title":"Cabaletta Bio, Inc.盘中异动 股价大涨5.12%报3.90美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2480358061","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480358061?lang=zh_cn&edition=full","pubTime":"2024-11-04 23:20","pubTimestamp":1730733630,"startTime":"0","endTime":"0","summary":"北京时间2024年11月04日23时20分，Cabaletta Bio, Inc.股票出现波动，股价大幅上涨5.12%。Cabaletta Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.01%。Cabaletta Bio, Inc.公司简介：Cabaletta Bio Inc 是一家临床阶段的生物技术公司，专注于发现和开发工程化 T 细胞疗法，并探索它们为 B 细胞介导的自身免疫性疾病患者提供深度和持久的、可能是治愈性治疗的潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104232030971a4316&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104232030971a4316&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CABA"],"gpt_icon":0},{"id":"2479039215","title":"Cabaletta Bio, Inc.盘中异动 早盘急速下挫5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479039215","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479039215?lang=zh_cn&edition=full","pubTime":"2024-10-31 22:39","pubTimestamp":1730385569,"startTime":"0","endTime":"0","summary":"北京时间2024年10月31日22时39分，Cabaletta Bio, Inc.股票出现异动，股价大幅跳水5.01%。Cabaletta Bio, Inc.股票所在的生物技术行业中，整体跌幅为3.43%。Cabaletta Bio, Inc.公司简介：Cabaletta Bio Inc 是一家临床阶段的生物技术公司，专注于发现和开发工程化 T 细胞疗法，并探索它们为 B 细胞介导的自身免疫性疾病患者提供深度和持久的、可能是治愈性治疗的潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031223929ab8be149&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031223929ab8be149&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CABA","BK4139"],"gpt_icon":0},{"id":"2478481394","title":"Cabaletta Bio, Inc.盘中异动 股价大涨6.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478481394","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478481394?lang=zh_cn&edition=full","pubTime":"2024-10-28 21:56","pubTimestamp":1730123799,"startTime":"0","endTime":"0","summary":"北京时间2024年10月28日21时56分，Cabaletta Bio, Inc.股票出现波动，股价快速上涨6.14%。Cabaletta Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.52%。Cabaletta Bio, Inc.公司简介：Cabaletta Bio Inc 是一家临床阶段的生物技术公司，专注于发现和开发工程化 T 细胞疗法，并探索它们为 B 细胞介导的自身免疫性疾病患者提供深度和持久的、可能是治愈性治疗的潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028215639971a2a8f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028215639971a2a8f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CABA","BK4139"],"gpt_icon":0},{"id":"2477655689","title":"Cabaletta Bio, Inc.盘中异动 股价大跌5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477655689","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477655689?lang=zh_cn&edition=full","pubTime":"2024-10-24 00:35","pubTimestamp":1729701345,"startTime":"0","endTime":"0","summary":"北京时间2024年10月24日00时35分，Cabaletta Bio, Inc.股票出现波动，股价急速下跌5.13%。Cabaletta Bio, Inc.股票所在的生物技术行业中，整体跌幅为1.11%。Cabaletta Bio, Inc.公司简介：Cabaletta Bio Inc 是一家临床阶段的生物技术公司，专注于发现和开发工程化 T 细胞疗法，并探索它们为 B 细胞介导的自身免疫性疾病患者提供深度和持久的、可能是治愈性治疗的潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241024003545a1e46bd3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241024003545a1e46bd3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CABA","BK4139"],"gpt_icon":0},{"id":"2477328355","title":"Cabaletta Bio, Inc.盘中异动 早盘股价大跌5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477328355","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477328355?lang=zh_cn&edition=full","pubTime":"2024-10-22 22:23","pubTimestamp":1729607015,"startTime":"0","endTime":"0","summary":"北京时间2024年10月22日22时23分，Cabaletta Bio, Inc.股票出现波动，股价大幅下跌5.09%。Cabaletta Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.82%。Cabaletta Bio, Inc.公司简介：Cabaletta Bio Inc 是一家临床阶段的生物技术公司，专注于发现和开发工程化 T 细胞疗法，并探索它们为 B 细胞介导的自身免疫性疾病患者提供深度和持久的、可能是治愈性治疗的潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241022222335971a1a00&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241022222335971a1a00&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CABA","BK4139"],"gpt_icon":0},{"id":"2477626866","title":"Cabaletta Bio, Inc.盘中异动 大幅下跌5.17%报4.65美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477626866","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477626866?lang=zh_cn&edition=full","pubTime":"2024-10-21 22:03","pubTimestamp":1729519399,"startTime":"0","endTime":"0","summary":"北京时间2024年10月21日22时03分，Cabaletta Bio, Inc.股票出现波动，股价大幅下跌5.17%。Cabaletta Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.12%。Cabaletta Bio, Inc.公司简介：Cabaletta Bio Inc 是一家临床阶段的生物技术公司，专注于发现和开发工程化 T 细胞疗法，并探索它们为 B 细胞介导的自身免疫性疾病患者提供深度和持久的、可能是治愈性治疗的潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241021220319971a1628&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241021220319971a1628&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CABA"],"gpt_icon":0},{"id":"2476925157","title":"Cabaletta Bio, Inc.盘中异动 股价大涨5.08%报4.55美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2476925157","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476925157?lang=zh_cn&edition=full","pubTime":"2024-10-17 02:06","pubTimestamp":1729101963,"startTime":"0","endTime":"0","summary":"北京时间2024年10月17日02时06分，Cabaletta Bio, Inc.股票出现波动，股价快速上涨5.08%。截至发稿，该股报4.55美元/股，成交量37.3006万股，换手率0.76%，振幅7.85%。Cabaletta Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.16%。Cabaletta Bio, Inc.公司简介：Cabaletta Bio Inc 是一家临床阶段的生物技术公司，专注于发现和开发工程化 T 细胞疗法，并探索它们为 B 细胞介导的自身免疫性疾病患者提供深度和持久的、可能是治愈性治疗的潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241017020604971a0af2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241017020604971a0af2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CABA","BK4139"],"gpt_icon":0},{"id":"2474722115","title":"Cabaletta Bio, Inc.盘中异动 下午盘股价大跌5.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2474722115","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474722115?lang=zh_cn&edition=full","pubTime":"2024-10-11 01:26","pubTimestamp":1728581191,"startTime":"0","endTime":"0","summary":"北京时间2024年10月11日01时26分，Cabaletta Bio, Inc.股票出现波动，股价快速下挫5.31%。Cabaletta Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.21%。Cabaletta Bio, Inc.公司简介：Cabaletta Bio Inc 是一家临床阶段的生物技术公司，专注于发现和开发工程化 T 细胞疗法，并探索它们为 B 细胞介导的自身免疫性疾病患者提供深度和持久的、可能是治愈性治疗的潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410110126319719f908&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410110126319719f908&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CABA","BK4139"],"gpt_icon":0},{"id":"2473782874","title":"Cabaletta Bio, Inc.盘中异动 股价大涨5.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2473782874","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473782874?lang=zh_cn&edition=full","pubTime":"2024-10-08 21:46","pubTimestamp":1728395185,"startTime":"0","endTime":"0","summary":"北京时间2024年10月08日21时46分，Cabaletta Bio, Inc.股票出现异动，股价急速拉升5.24%。Cabaletta Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.57%。Cabaletta Bio, Inc.公司简介：Cabaletta Bio Inc 是一家临床阶段的生物技术公司，专注于发现和开发工程化 T 细胞疗法，并探索它们为 B 细胞介导的自身免疫性疾病患者提供深度和持久的、可能是治愈性治疗的潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241008214625ab687d4a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241008214625ab687d4a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CABA"],"gpt_icon":0},{"id":"2473111105","title":"Cabaletta Bio, Inc.盘中异动 早盘股价大跌5.45%报4.03美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2473111105","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473111105?lang=zh_cn&edition=full","pubTime":"2024-10-07 21:38","pubTimestamp":1728308316,"startTime":"0","endTime":"0","summary":"北京时间2024年10月07日21时38分，Cabaletta Bio, Inc.股票出现波动，股价大幅下跌5.45%。截至发稿，该股报4.03美元/股，成交量2.599万股，换手率0.05%，振幅5.52%。Cabaletta Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.15%。Cabaletta Bio, Inc.公司简介：Cabaletta Bio Inc 是一家临床阶段的生物技术公司，专注于发现和开发工程化 T 细胞疗法，并探索它们为 B 细胞介导的自身免疫性疾病患者提供深度和持久的、可能是治愈性治疗的潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100721383698e3ad98&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100721383698e3ad98&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CABA","BK4139"],"gpt_icon":0},{"id":"2472966390","title":"Cabaletta Bio, Inc.盘中异动 早盘股价大涨5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2472966390","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472966390?lang=zh_cn&edition=full","pubTime":"2024-10-04 22:51","pubTimestamp":1728053508,"startTime":"0","endTime":"0","summary":"北京时间2024年10月04日22时51分，Cabaletta Bio, Inc.股票出现异动，股价急速拉升5.10%。Cabaletta Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.15%。Cabaletta Bio, Inc.公司简介：Cabaletta Bio Inc 是一家临床阶段的生物技术公司，专注于发现和开发工程化 T 细胞疗法，并探索它们为 B 细胞介导的自身免疫性疾病患者提供深度和持久的、可能是治愈性治疗的潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410042251489719e679&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410042251489719e679&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CABA"],"gpt_icon":0},{"id":"2472492614","title":"Cabaletta Bio, Inc.盘中异动 早盘股价大跌5.10%报4.38美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2472492614","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472492614?lang=zh_cn&edition=full","pubTime":"2024-10-03 22:42","pubTimestamp":1727966543,"startTime":"0","endTime":"0","summary":"北京时间2024年10月03日22时42分，Cabaletta Bio, Inc.股票出现异动，股价急速下跌5.10%。Cabaletta Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.91%。Cabaletta Bio, Inc.公司简介：Cabaletta Bio Inc 是一家临床阶段的生物技术公司，专注于发现和开发工程化 T 细胞疗法，并探索它们为 B 细胞介导的自身免疫性疾病患者提供深度和持久的、可能是治愈性治疗的潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100322422498e3a6fb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100322422498e3a6fb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CABA","BK4139"],"gpt_icon":0},{"id":"2472239529","title":"Cabaletta Bio, Inc.盘中异动 大幅下跌5.60%报4.38美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2472239529","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472239529?lang=zh_cn&edition=full","pubTime":"2024-10-02 21:43","pubTimestamp":1727876632,"startTime":"0","endTime":"0","summary":"北京时间2024年10月02日21时43分，Cabaletta Bio, Inc.股票出现波动，股价快速下挫5.60%。Cabaletta Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.72%。Cabaletta Bio, Inc.公司简介：Cabaletta Bio Inc 是一家临床阶段的生物技术公司，专注于发现和开发工程化 T 细胞疗法，并探索它们为 B 细胞介导的自身免疫性疾病患者提供深度和持久的、可能是治愈性治疗的潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100221435398e3a356&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100221435398e3a356&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CABA","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cabalettabio.com","stockEarnings":[{"period":"1week","weight":-0.3252},{"period":"1month","weight":-0.3498},{"period":"3month","weight":-0.3326},{"period":"6month","weight":-0.7547},{"period":"1year","weight":-0.8263},{"period":"ytd","weight":-0.8665}],"compareEarnings":[{"period":"1week","weight":-0.0208},{"period":"1month","weight":0.0059},{"period":"3month","weight":0.0567},{"period":"6month","weight":0.1063},{"period":"1year","weight":0.301},{"period":"ytd","weight":0.2324}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Cabaletta Bio, Inc.于2017年4月根据特拉华州法律注册成立。该公司是一家临床阶段的生物技术公司，专注于发现和开发工程化T细胞疗法，这些疗法有可能为患有自身免疫性疾病的患者提供一种深度和持久的，也许是治疗性的治疗。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.047408},{"month":2,"riseRate":0.2,"avgChangeRate":-0.139771},{"month":3,"riseRate":0.2,"avgChangeRate":-0.173851},{"month":4,"riseRate":0.4,"avgChangeRate":-0.089046},{"month":5,"riseRate":0.4,"avgChangeRate":0.011007},{"month":6,"riseRate":0.4,"avgChangeRate":-0.019407},{"month":7,"riseRate":0.6,"avgChangeRate":0.002175},{"month":8,"riseRate":0.4,"avgChangeRate":-0.014107},{"month":9,"riseRate":0.6,"avgChangeRate":-0.036797},{"month":10,"riseRate":0.6,"avgChangeRate":0.296033},{"month":11,"riseRate":0.666667,"avgChangeRate":0.344648},{"month":12,"riseRate":0.6,"avgChangeRate":0.132954}],"exchange":"NASDAQ","name":"Cabaletta Bio","nameEN":"Cabaletta Bio"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Cabaletta Bio(CABA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Cabaletta Bio(CABA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Cabaletta Bio,CABA,Cabaletta Bio股票,Cabaletta Bio股票老虎,Cabaletta Bio股票老虎国际,Cabaletta Bio行情,Cabaletta Bio股票行情,Cabaletta Bio股价,Cabaletta Bio股市,Cabaletta Bio股票价格,Cabaletta Bio股票交易,Cabaletta Bio股票购买,Cabaletta Bio股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Cabaletta Bio(CABA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Cabaletta Bio(CABA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}